Dispelling the Myth of a Pandemic of the Unvaccinated
DOI:
https://doi.org/10.56098/ijvtpr.v2i1.38Keywords:
Ontario Science Table, hospitalizations due to COVID-19, pandemic of the unvaccinated, methodological errorsAbstract
We have reanalyzed the Ontario Science Table data on hospitalizations for COVID-19 in COVID-19 vaccinated versus unvaccinated patients admitted to hospital during various waves of the pandemic. In spite of the Ontario Science Table and the mass media claims that the unvaccinated were the dominant population being hospitalized, a more rigorous evaluation of the existing data shows that this narrative is not correct for the latter waves of COVID-19. We identify a series of methodological issues that may have led to their conclusions and why such issues may have resulted in policies that have been largely ineffective.
References
Akhtar-Danesh, N., Baumann, A., Crea-Arsenio, M., Antonipillai, V. (2022). COVID-19 excess mortality among long-term care residents in Ontario, Canada. PLoS One 2022;17:e0262807. https://doi.org/10.1371/journal.pone.0262807
Brown, CM., Vostok, J., Johnson, H., et al. (2021, July). Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings—Barnstable County, Massachusetts, July 2021. Morbidity Mortality Weekly Report 2021;70:1059. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367314/
Brown, KA., Jones, A., Daneman, N., et al. (2021). Association between nursing home crowding and COVID-19 infection and mortality in Ontario, Canada. JAMA Internal Medicine 2021;181:229-36. https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2772335
Burdin, N., Handy, LK., Plotkin, SA. (2017). What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines. Cold Spring Harbor Perspectives in Biology 2017;9. https://pubmed.ncbi.nlm.nih.gov/28289064/
Canadian Blood Services COVID-19 Seroprevalence Brief Report #19A: February 1-15, 2022 Survey. https://www.covid19immunitytaskforce.ca/wp-content/uploads/2022/04/covid-19-report-feb-2022-march-2022.pdf
Canadian Institute for Health Information. (2021). The impact of COVID-19 on long-term care in Canada: Focus on the first 6 months. CIHI Ottawa, ON, Canada; 2021.
CBC News. (2021, August 17). Ontario announces mandatory vaccine plans for health, education workers; 3rd doses for some. CBC News. Retrieved January 29, 2022, from https://www.cbc.ca/news/canada/toronto/ontario-COVID-vaccines-requirement-health-care-education-1.6143378
Centers for Disease Control and Prevention. (2021, October 29). Frequently asked questions about Coronavirus (COVID-19) for laboratories — Interpreting results of diagnostic tests. Retrieved October 29, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/lab/faqs.html#Interpreting-Results-of-Diagnostic-Tests
Chow, N., Gallo, L., Busse, JW. (2018). Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making. Precision Clinical Medicine 2018; 1:60-4. https://doi.org/10.1093/pcmedi/pby009
City of Toronto. (2022). COVID-19: Epidemiological summary of cases - Which COVID-19 cases required medical attention? Retrieved January 29, 2022, from https://www.toronto.ca/home/COVID-19/COVID-19-pandemic-data/COVID-19-epidemiological-summary-of-cases-data/
Classen, B. (2021). "US COVID-19 vaccines proven to cause more harm than good based on pivotal clinical trial data analyzed using the proper scientific endpoint, “all cause severe morbidity”. Trends in Internal Medicine 2021; 1 (1): 1-6. https://anony.link/https://www.scivisionpub.com/pdfs/us-covid19-vaccines-proven-to-cause-more-harm-than-good-based-on-pivotal-clinical-trial-data-analyzed-using-the-proper-scientific--1811.pdf
Cohen, KW., Linderman, SL., Moodie, Z., et al. (2021). Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Reports Medicine 2021;2:100354. https://doi.org/10.1016/j.xcrm.2021.100354
Collie, S., Champion, J., Moultrie, H., Bekker, L-G., Gray, G. (2021). Effectiveness of BNT162b2 vaccine against omicron variant in South Africa. New England Journal of Medicine 2021. https://www.nejm.org/doi/full/10.1056/NEJMc2119270
Connell, AR., Connell, J., Leahy, TR., Hassan, J. (2020). Mumps outbreaks in vaccinated populations—Is it time to re-assess the clinical efficacy of vaccines? Frontiers in Immunology 2020;11. https://doi.org/10.3389/fimmu.2020.02089
Crooke, SN., Ovsyannikova, IG., Poland, GA., Kennedy, RB. (2019). Immunosenescence and human vaccine immune responses. Immunology of Ageing 2019;16:25. https://link.springer.com/article/10.1186/s12979-019-0164-9
Dejnirattisai, W., Shaw, R. H., Supasa, P., Liu, C., Stuart, A. S., Pollard, A. J., Liu, X., Lambe, T., Crook, D., Stuart, D. I., Mongkolsapaya, J., Nguyen-Van-Tam, J. S., Snape, M. D., & Screaton, G. R. (2022). Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunization serum. The Lancet, 399(10321), 234–236. https://doi.org/10.1016/S0140-6736(21)02844-0
Duintjer Tebbens, RJ., Pallansch, MA., Chumakov, KM., et al. (2013). Expert review on poliovirus immunity and transmission. Risk Anal 2013;33:544-605. https://doi.org/10.1111/j.1539-6924.2012.01864.x
Dunham, J. (2021, August 19). Unvaccinated? Here are some of the things that are off-limits to you in Canada. CTV News. Retrieved January 29, 2022, from https://www.ctvnews.ca/health/coronavirus/unvaccinated-here-are-some-of-the-things-that-are-off-limits-to-you-in-canada-1.5553655
Dykgraaf, SH., Matenge, S., Desborough, J., et al. (2021). Protecting nursing homes and long-term care facilities from COVID-19: A rapid review of international evidence. Journal of the American Medical Directory Association 2021;22:1969-88. https://doi.org/10.1016/j.jamda.2021.07.027
Edmonson, MB., Addiss, DG., McPherson, JT., Berg, JL., Circo, SR., Davis, JP. (1990). Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 1990;263:2467-71. https://jamanetwork.com/journals/jama/article-abstract/381746
Focosi, D., Maggi, F., Casadevall, A. (2022). Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence. Viruses 2022;14:187. https://www.mdpi.com/1999-4915/14/2/187
Gee, J., Marquez, P., Su, J., et al. (2021). First month of COVID-19 vaccine safety monitoring - United States, December 14, 2020-January 13, 2021. MMWR Morb Mortal Wkly Rep 2021;70:283-8. https://pubmed.ncbi.nlm.nih.gov/33630816/ Goodfield, K. (2021, February 2). Ontario records 745 new COVID-19 cases, 14 deaths while citing data issue. CTV News. Retrieved January 29, 2022, from https://toronto.ctvnews.ca/ontario-records-745-new-COVID-19-cases-14-deaths-while-citing-data-issue-1.5292064
Government of Canada. (2021a). Health Canada. Reported side effects following COVID-19 vaccination in Canada. Retrieved January 29, 2022, from https://health-infobase.canada.ca/COVID-19/vaccine-safety/
Government of Canada. (2021b). Health Canada authorizes use of Comirnaty (the Pfizer-Biontech COVID-19 Vaccine) in children 5 to 11 years of age. Retrieved January 29, 2022, from https://www.canada.ca/en/health-canada/news/2021/11/health-canada-authorizes-use-of-comirnaty-the-pfizer-biontech-COVID-19-vaccine-in-children-5-to-11-years-of-age.html
Government of Canada. (2022). Historical weather and climate data for Toronto International A Station. Retrieved January 29, 2022, from https://climate.weather.gc.ca/climate_data/daily_data_e.html?StationID=51459
Government of Ontario. (2021). COVID-19: Hospitalizations. ontario.ca, 2021. Retrieved January 29, 2022, from https://COVID-19.ontario.ca/data/hospitalizations#hospitalizationsByICUBed
Government of Ontario. (2022). Ontario Data Catalogue - COVID-19 vaccine data in Ontario. Retrieved January 29, 2022, from https://data.ontario.ca/dataset/COVID-19-vaccine-data-in-ontario
Government of Ontario Ministry of Health. (2021). Management of cases and contacts of COVID-19 in Ontario August 11, 2021 (version 13.0). Retrieved January 29, 2022, from https://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/contact_mngmt/management_cases_contacts.pdf
GRADE Working Group. (2004). Grading quality of evidence and strength of recommendations. BMJ 2004 Jun 19; 328(7454): 1490 https://doi.org/10.1136/bmj.328.7454.1490
Heffernan, JM., Keeling, MJ. (2008). An in-host model of acute infection: measles as a case study. Theoretical Population Biology 2008;73:134-47. https://www.sciencedirect.com/science/article/pii/S0040580907001190
Hellerstein, M. (2020). What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2? Vaccine X 2020;6:100076. https://www.sciencedirect.com/science/article/pii/S2590136220300231
Herhalt, C. (2021, September 5). Unvaccinated Ontario teachers must submit to twice weekly COVID-19 testing. CTV News. Retrieved January 29, 2022, from https://toronto.ctvnews.ca/unvaccinated-ontario-teachers-must-submit-to-twice-weekly-COVID-19-testing-1.5574333
Hogan, A., Winskill, P., Watson, O., et al. (2020, September 25). Report 33: modelling the allocation and impact of a COVID-19 vaccine. Imperial College of London. Retrieved January 29, 2022, from https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/COVID-19/report-33-vaccine/
Kompaniyets, L., Goodman, AB., Belay, B., et al. (2021). Body mass index and risk for COVID-19–related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death—United States, March–December 2020. Morb Mortal Weekly Rep 2021;70:355. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951819/
Keegan, LT., Truelove, S., Lessler, J. (2021). Analysis of vaccine effectiveness against COVID-19 and the emergence of delta and other variants of concern in Utah. JAMA Network Open 2021;4:e2140906-e. https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2787438
Keeling, M., Tildesley, M., House, T., Danon, L. (2013). The mathematics of vaccination. Math Today 2013;49:40-3. https://cdn.ima.org.uk/wp/wp-content/uploads/2016/06/Mathematics_of_Vaccination.pdf
Kompaniyets, L., Pennington, AF., Goodman, AB., et al. (2021). Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Preventing Chronic Disease 2021;18:E66. http://dx.doi.org/10.5888/pcd18.210123
Koopman, JS., Henry, CJ., Park, JH., Eisenberg, MC., Ionides, EL., Eisenberg, JN. (2017). Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped. Epidemics 2017;20:21-36. https://doi.org/10.1016/j.epidem.2017.02.013
Lewnard, JA., Grad, YH. (2018). Vaccine waning and mumps re-emergence in the United States. Science Translational Medicine 2018;10. https://www.science.org/doi/abs/10.1126/scitranslmed.aao5945
Lopez Bernal, J., Andrews, N., Gower, C., et al. (2021). Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) Variant. New England Journal of Medicine 2021;385:585-94. https://www.nejm.org/doi/full/10.1056/NEJMoa2108891
Madden, K., Bhandari, M. (2020). Can evidence-based medicine and personalized medicine coexist? Personalized Hip and Knee Joint Replacement 2020:1-5. https://library.oapen.org/bitstream/handle/20.500.12657/39985/2020_Book_PersonalizedHipAndKneeJointRep.pdf?sequence=1#page=16
Mann, CJ. (2003). Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emergency Medicine Journal 2003;20:54-60.
Marrocco, FN., Coke, A., Kitts, J. (2021, April 30). Ontario’s long-term care COVID-19 commission final report. Retrieved January 29, 2022, from http://www.ltccommission-commissionsld.ca/report/pdf/20210623_LTCC_AODA_EN.pdf
Mathias, RG., Meekison, WG., Arcand, TA., Schechter, MT. (1989). The role of secondary vaccine failures in measles outbreaks. American Journal of Public Health 1989;79:475-8. https://doi.org/10.2105/AJPH.79.4.475
Mayo Clinic (1998-2022): https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/herd-immunity-and-coronavirus/art-20486808
Mina, MJ., Peto, TE., García-Fiñana, M., Semple, MG., Buchan, IE. (2021). Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19. The Lancet 2021;397:1425-7. https://doi.org/10.1016/S0140-6736(21)00425-6
Misra, S. (2012). Randomized double blind placebo control studies, the "Gold Standard" in intervention based studies. Indian Journal of Sexually Transmitted Disease AIDS 2012;33:131-4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505292/
Morawska, L., Tang, JW., Bahnfleth, W., et al. (2020). How can airborne transmission of COVID-19 indoors be minimized? Environment International 2020;142:105832. https://doi.org/10.1016/j.envint.2020.105832
Morgan, G. (2021, October 18). Most COVID vaccinated Canadians mistrustful of the unvaccinated and medical exemptions: poll. National Post. Retrieved January 29, 2022, from https://nationalpost.com/news/canada/most-COVID-vaccinated-canadians-mistrustful-of-the-unvaccinated-and-medical-exemptions-poll
Nevada Division of Public and Behavioral Health. (2021, December 3). Nevada Board of H ealth Meeting (pp. 103). Retrieved January 29, 2022, from https://dpbh.nv.gov/uploadedFiles/dpbhnvgov/content/Boards/BOH/Meetings/2021/Public%20Comments%20276%20to%20294.pdf
Ontario Hospital Association. (2021). Fact sheet on hospital capacity. Retrieved January 29, 2022, from https://www.oha.com/Bulletins/OHA%20Fact%20Sheet%20on%20Hospital%20Capacity%20and%20Projections%20Jan%2015%202021.pdf
Ontario Ministry of Health. (2021). COVID-19 fully vaccinated and previously positive individuals: Case, contact and outbreak management interim guidance. Retrieved January 29, 2022, from https://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/contact_mngmt/COVID-19_fully_vaccinated_interim_guidance.pdf
Parsons, P. (2022) Health expert urges caution after blood-testing firm claims ‘pandemic is over’ in Albert hamlet. https://www.cbc.ca/news/canada/edmonton/private-covid-19-antibody-tests-la-crete-alberta-1.6307357
Phillips, N. (2021). The coronavirus is here to stay-here’s what that means. Nature 2021;590:382-4. https://www.nature.com/articles/d41586-021-00396-2
Pollard, AJ., Bijker, EM. (2021). A guide to vaccinology: from basic principles to new developments. Nature Reviews Immunology 2021;21:83-100. https://www.nature.com/articles/s41577-020-00479-7
Pringle J. (2021, October 22). Unvaccinated Ottawa police employees must undergo testing every three days under COVID-19 vaccine policy. CTV News. Retrieved January 29, 2022, from https://ottawa.ctvnews.ca/unvaccinated-ottawa-police-employees-must-undergo-testing-every-three-days-under-COVID-19-vaccine-policy-1.5634864
Public Health Ontario. (2020). An overview of cycle threshold values and their role in SARS-CoV-2 real-time PCR test interpretation. Retrieved January 29, 2022, from https://www.publichealthontario.ca/-/media/documents/ncov/main/2020/09/cycle-threshold-values-sars-cov2-pcr.pdf?la=en
Public Health Ontario. (2021a). Explained: COVID-19 PCR testing and cycle thresholds. Retrieved January 29, 2022, from https://www.publichealthontario.ca/en/about/blog/2021/explained-COVID19-pcr-testing-and-cycle-thresholds
Public Health Ontario. (2021b). Trends of COVID-19 incidence in Ontario. Retrieved January 29, 2022, from https://www.publichealthontario.ca/-/media/documents/ncov/epi/COVID-19-epi-trends-incidence-ontario.pdf?sc_lang=en
Public Health Ontario. (2022a). Sars-Cov-2 whole genome sequencing in Ontario. Retrieved January 29, 2022, from https://www.publichealthontario.ca/-/media/documents/ncov/epi/COVID-19-sars-cov2-whole-genome-sequencing-epi-summary.pdf?sc_lang=en
Public Health Ontario. (2022b). Ontario COVID-19 data tool. Retrieved January 29, 2022, from https://www.publichealthontario.ca/en/data-and-analysis/infectious-disease/COVID-19-data-surveillance/COVID-19-data-tool?tab=summary
Public Health Ontario. (2022c). Confirmed cases of COVID-19 following vaccination in Ontario: December 14, 2020 to January 16, 2022. Retrieved January 29, 2022, from https://www.publichealthontario.ca/-/media/documents/ncov/epi/COVID-19-epi-confirmed-cases-post-vaccination.pdf?sc_lang=en
Ranstam, J. (2019). Hypothesis-generating and confirmatory studies, Bonferroni correction, and pre-specification of trial endpoints. Acta Orthopaedica 2019;90:297-. https://doi.org/10.1080/17453674.2019.1612624
Read, AF., Mackinnon, MJ. (2009). Pathogen evolution in a vaccinated world. Evolution in Health and Disease 2008;2:139-52. http://www.thereadgroup.net/wp-content/uploads/Read&MackinnonStearns&KoelleaChap11.pdf
Read, AF., Baigent, SJ., Powers, C., et al. (2015). Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biology 2015;13:e1002198. https://doi.org/10.1371/journal.pbio.1002198
Reis, BY., Barda, N., Leshchinsky, M., et al. (2021). Effectiveness of BNT162b2 vaccine against Delta variant in adolescents. New England Journal of Medicine 2021;385:2101-3. https://www.nejm.org/doi/full/10.1056/NEJMc2114290
Science Table - COVID-19 Advisory for Ontario. (2021, September 28). Update on COVID-19 projections - Science advisory and modelling consensus tables. Retrieved January 29, 2022, from https://COVID19-sciencetable.ca/wp-content/uploads/2021/09/Update-on-COVID-19-Projections_2021.09.28_English-2.pdf
Scott, J., Richterman, A., Cevik, M. (2021). COVID-19 vaccination: evidence of waning immunity is overstated. BMJ 2021;374:n2320. https://www.bmj.com/content/374/bmj.n2320
Shah, P., Thornton, I., Turrin, D., & Hipskind, J. E. (2021). Informed Consent. In StatPearls. StatPearls Publishing.
Singanayagam, A., Hakki, S., Dunning, J., et al. (2021). Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infectious Diseases 2021;22:183-95. https://doi.org/10.1016/S1473-3099(21)00648-4
Sundaram, M., Nasreen, S., Calzavara, A., et al. (2021). Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments. Vaccine 2021;39:5265-70. https://doi.org/10.1016/j.vaccine.2021.07.060
Talari, K., Goyal, M. (2020). Retrospective studies — utility and caveats. Journal of the Royal College of Physicians Edinburgh 2020;50:398-402. https://www.researchgate.net/profile/Mohit-Goyal-6/publication/348395519_Retrospective_studies_-_Utility_and_caveats/links/600e9ec9a6fdccdcb87aeb32/Retrospective-studies-Utility-and-caveats.pdf
Tang, S., Mao, Y., Jones, RM., et al. (2020). Aerosol transmission of SARS-CoV-2? Evidence, prevention and control. Environment International 2020;144:106039-. https://doi.org/10.1016/j.envint.2020.106039
Thiruvengadam, R., Awasthi, A., Medigeshi, G., et al. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses. Lancet Infectious Diseases 2021. https://doi.org/10.1016/S1473-3099(21)00680-0
Thomas, SJ., Moreira, ED., Kitchin, N., et al. (2021). Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. New England Journal of Medicine 2021;385:1761-73. https://www.nejm.org/doi/full/10.1056/NeJMoa2110345
Thompson, D-C., Barbu, M-G., Beiu, C., et al. (2021). The impact of COVID-19 pandemic on long-term care facilities worldwide: An overview on international issues. BioMed Research International 2020;2020:8870249. https://doi.org/10.1155/2020/8870249
Torgovnick, J. (2021). Effectiveness of COVID-19 vaccines against the B.1.617.2 (delta) variant. New England Journal of Medicine 2021. https://www.nejm.org/doi/10.1056/NEJMc2113090
UK Government — Medicines & Healthcare Products Regulatory Agency. (2021). Coronavirus vaccine - weekly summary of Yellow Card reporting. Retrieved January 29, 2022, from https://www.gov.uk/government/publications/coronavirus-COVID-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting
U.S. Department of Health and Human Services (HHS). (2021). Vaccine Adverse Event Reporting System - VAERS Data. Retrieved January 29, 2022, from https://vaers.hhs.gov/data.html
Vygen, S., Fischer, A., Meurice, L., et al. (2016). Waning immunity against mumps in vaccinated young adults, France 2013. European Surveillance 2016;21:30156. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.10.30156
Woolf, SH., Chapman, DA., Lee, JH. (2021). COVID-19 as the leading cause of death in the United States. JAMA 2021;325:123-4. https://jamanetwork.com/journals/jama/article-abstract/2774465
World Health Organization. (2020, December 31). Preparedness WTE. Coronavirus disease (COVID-19): Serology, antibodies and immunity. Retrieved January 29, 2022, from https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-COVID-19-serology
World Health Organization. (2021). Infection prevention and control guidance for long-term care facilities in the context of COVID-19: interim guidance, 8 January 2021. Retrieved January 29, 2022, from https://apps.who.int/iris/rest/bitstreams/1326056/retrieve
Wyller, TB., Kittang, BR., Ranhoff, AH., Harg, P., Myrstad, M. (2021). Nursing home deaths after COVID-19 vaccination. Tidsskrift for Den norske legeforening. Tidsskrift for Praktisk Medicin, ny Raekke 2021 May;141. https://pubmed.ncbi.nlm.nih.gov/34018389/
Yewdell, JW. (2021). Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread. PLoS Pathology 2021;17:e1009509. https://doi.org/10.1371/journal.ppat.1009509
Young, L. (2021, September 29). Unvaccinated 60 times more likely to end up in ICU with COVID-19, Ontario data shows. GlobalNews. https://globalnews.ca/news/8230051/COVID-vaccine-hospitalization-risk-ontario/
Zhang, Z., Chen, M., Ma, R., Pan, J., Suo, L., Lu, L. (2018). Outbreak of measles among persons with secondary vaccine failure, China, 2018. Human Vaccine Immunotherapy 2020;16:358-62. https://doi.org/10.1080/21645515.2019.1653742
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Deanna McLeod, Ilidio Martins, Stephen Pelech, Ceilidh Beck, Christopher A Shaw
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The copyright for materials in this journal, IJVTPR, is owned by the author. The author, however, grants first right of publication to the journal, IJVTPR and assures the editorial staff of the journal that the work submitted has not simultaneously been submitted to any other journal, nor is it under consideration for publication by any other journal. If any portion of the work submitted has appeared elsewhere, the quoted material is properly cited and credit is given to the original publisher. The submitting author (or the principal and corresponding author of the work) also assures the editors of IJVTPR that he or she has obtained all required written permissions from any quoted authors or publishers of quoted materials. The submitting author also agrees to hold IJVTPR and its editorial staff harmless from any infractions of copyright law that may be discovered at any time in the future in the submitted work. The author assures the editorial staff at IJVTPR that none of the work submitted is plagiarized, and that any recycled or precycled material by the author is identified as such with proper credits in the text to any other parties holding a copyright interest in the quoted material.